Meeting Coverage

Dimethyl Fumarate Reduces Risk for First Clinical Event in RIS

Nov 8, 2022

For the first time, a randomized, placebo-controlled trial demonstrated beneficial effects of a...

Inebilizumab Effective in NMOSD Despite Fc Receptor Polymorphisms

Nov 8, 2022

For a presentation at the 2022 European Committee for Treatment and Research in Multiple Sclerosis...

REMIND-MS Trial: Initial Results

Nov 8, 2022

Data from a randomized controlled trial presented at the European Committee for Treatment and...

Half of IBS Videos Shared on TikTok Posted by Influencers

Nov 8, 2022

Nearly half of the TikTok videos on irritable bowel syndrome (IBS) are shared by social media...

Gut-Directed Hypnotherapy Via Mobile App Improves IBS Symptoms

Nov 8, 2022

Gut-directed hypnotherapy (GDH) delivered by a mobile app improved overall and individual...

Patients With NMOSD Cognitively Impaired Regardless of Serostatus

Nov 4, 2022

A prospective, longitudinal, multicenter study of 217 patients with neuromyelitis optica spectrum...

New Data on the Safety of Anti-CD20 mAbs Around Pregnancy

Nov 4, 2022

A new study suggests B-cell depleting anti-CD20 monoclonal antibodies (mAbs) such as ocrelizumab...

Chronic, Active MS Lesions Respond Poorly to Anti-CD20 Antibodies

Nov 4, 2022

Anti-CD20 therapies do not fully resolve chronic, active/smoldering lesions, visible on MRI as...

How & When to Make a Timely Switch to High-Efficacy DMT

Nov 4, 2022

For a variety of reasons, patients with relapsing-remitting MS (RRMS) together with their...

Fingolimod in Pediatric MS: Results of Up to 6 years

Nov 4, 2022

In patients with aged 10-17 and treated with fingolimod for up to 6 years in the PARADIGMS study,...

Autologous Hematopoietic Stem Cell Transplantation Vs DMTs

Nov 4, 2022

From observational, single-arm cohorts, autologous hematopoietic stem cell transplantation (AHSCT)...

NMOSD: True AQP4 Seroconversion Is Rare

Nov 4, 2022

At a prize-winning poster presented at the European Committee for Treatment and Research in...

Teriflunomide Found Safe in Long-Term Follow-up

Nov 4, 2022

A large study conducted in European nationwide data sources found no evidence that teriflunomide...

CME at ACR

Nov 3, 2022

The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Physicians can earn up to 168.50 AMA PRA Category 1...

Meeting Schedule

Nov 3, 2022

Thursday, 11/10 7:30 AM–6:45 PM Advance Programming 7:30 AM-4:50 PM Global Rheumatology Summit VIRTUAL ONLY 12:00–6:45 PM FIT Program Friday, 11/11 9:00 AM–6:00 PM Advance Programming Review Course Basic & Clinical Research...

Featured Sessions

Nov 3, 2022

Keynote Lecture: Physician, Patients and the Nature of Heroism in Medicine November 12, 9:00–9:45 AM ET Speaker: Abraham Verghese, MD Abraham Verghese, MD, vice chair of the Department of Medicine at Stanford University School...